QC
WST icon

Quent Capital’s West Pharmaceutical WST Stock Holding History

Quent Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5K Buy
32
+16
+100% +$4.89K ﹤0.01% 1216
2026
Q1 		$4.01K Sell
16
-25
-61% -$6.22K ﹤0.01% 1310
2025
Q4 		$11.3K Sell
41
-1
-2% -$274 ﹤0.01% 1129
2025
Q3 		$11K Buy
+42
New +$10.2K ﹤0.01% 989
2025
Q2 		– Sell
-22
Closed -$4.92K – 1268
2025
Q1 		$4.92K Sell
22
-22
-50% -$6.06K ﹤0.01% 1020
2024
Q4 		$14.4K Buy
44
+9
+26% +$2.83K ﹤0.01% 861
2024
Q3 		$10.5K Sell
35
-15
-30% -$4.59K ﹤0.01% 1004
2024
Q2 		$16.5K Hold
50
– – ﹤0.01% 899
2024
Q1 		$19.8K Sell
50
-21
-30% -$7.77K ﹤0.01% 879
2023
Q4 		$25K Buy
71
+21
+42% +$7.43K ﹤0.01% 785
2023
Q3 		$18.8K Hold
50
– – ﹤0.01% 805
2023
Q2 		$19.1K Hold
50
– – ﹤0.01% 800
2023
Q1 		$17.3K Sell
50
-19
-28% -$5.55K ﹤0.01% 807
2022
Q4 		$16.3K Sell
69
-33
-32% -$7.82K ﹤0.01% 809
2022
Q3 		$25K Hold
102
– – 0.01% 703
2022
Q2 		$31K Sell
102
-51
-33% -$16.6K 0.01% 634
2022
Q1 		$63K Sell
153
-1,411
-90% -$552K 0.01% 538
2021
Q4 		$734K Buy
+1,564
New +$673K 0.16% 111

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quent Capital's WST Position: Q2 2026 in Review

Quent Capital increased its West Pharmaceutical (WST) stake by 100% in Q2 2026, buying an estimated $4.89K and bringing the position to 32 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Quent Capital first reported a position in WST in Q4 2021 and has held it in 18 quarters since. The position peaked at $734K in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Quent Capital held 32 shares of West Pharmaceutical worth $11.5K as of Q2 2026.
  • Quent Capital bought 16 West Pharmaceutical shares in Q2 2026, an estimated $4.89K.
  • West Pharmaceutical made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1216 holding.
  • Quent Capital first reported a position in West Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's West Pharmaceutical position peaked at $734K in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.